This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As veterinarians, flu scientists, and biosecurity experts, we have watched with growing concern the rise in H5N1 avian influenza in cats. Since 2022, more than 100 domesticated cats in the United States have had confirmed infections — some house pets, some barn cats, some feral — with high mortality, although mortality data remain undocumented on federal sites.
Almost 120,000 packs of Boots Paracetamol have been recalled because of a packaging error where they are incorrectly labelled as Aspirin on the foil blister. The Medicines and Healthcare products Regulatory Agency (MHRA) has today issued a recall alert for a specific batch of Boots Paracetamol 500mg (16s) and has advised the public to stop […] The post Boots Paracetamol batch recalled after being wrongly labelled as Aspirin appeared first on The Pharmacist.
The Food and Drug Administration scolded a company for a promotional display that falsely claimed its brand-name medicine was more effective than generic versions, which is apparently the first time the agency office responsible for monitoring advertising has cited such an issue. In a Feb. 3 letter posted on the FDA website this week, the Office of Prescription Drug Promotion wrote that Edenbridge Pharmaceuticals displayed a panel about its Hemady treatment for multiple myeloma in a conference e
Dr. Adam J. Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: PBM Industry Update: Trends, Challenges, and What's Ahead This event will be broadcast live on Friday, April 4, 2025, from 12:00 p.m. to 1:30 p.m. ET This page describes the event and explains how to purchase a registration.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
UnitedHealth Group moved a step closer to ending a yearslong legal battle with the federal government that began with a whistleblower who alleged the company bilked billions of dollars through the Medicare Advantage program. A special master assigned to the case by the judge issued a recommendation late Monday in favor of UnitedHealth, saying the Department of Justice was “lacking any evidence” to prove the company illegally withheld at least $2 billion in overpayments from t
Some hormonal contraceptives are associated with a small but significant increased risk of stroke and heart attack, according to a large and detailed study from Denmark. The analysis was based on national prescription records for more than two million Danish women between 1996 and 2021. It showed that contemporary oestrogen-progestin and progestin-only contraceptives were associated […] The post Heart attack and stroke risk higher with certain hormonal contraceptives appeared first on The
For decades, I was a cog in the machine, part of a health care system that has drifted far from its original mission — to care for people. I worked tirelessly at the top health care organizations, including UnitedHealthcare and Magellan. Ultimately, I was driven by the demands of the system, rationalizing success through stock options and promotions, even as I was forced further away from the patients whose well-being was supposed to be at the center of it all.
322
322
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
For decades, I was a cog in the machine, part of a health care system that has drifted far from its original mission — to care for people. I worked tirelessly at the top health care organizations, including UnitedHealthcare and Magellan. Ultimately, I was driven by the demands of the system, rationalizing success through stock options and promotions, even as I was forced further away from the patients whose well-being was supposed to be at the center of it all.
Voyager Therapeutics’ progress with drug candidates targeting tau marks a step in how the industry is walking multiple paths toward new therapeutic options.
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Pfizer recently rolled out a new generative AI product, called Health Answers by Pfizer , designed to provide consumers trustworthy information about common questions.
After three years at the helm of controversial virtual mental health company Cerebral , David Mou has moved on and is ready to try again. He’s teamed up with Thomas Insel to form a new venture that hopes to address what the founders see as skewed incentives that sent many mental health companies down the wrong path. Mou and Insel are both psychiatrists and Insel, who led the National Institute of Mental Health for over a decade before a stint at Verily, has been a mentor to Mou through a
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Asda has launched a new earache service for patients aged 18 and over across its 226 pharmacies in England. The acute otitis media service is priced at 25 and offers same day appointments with an Asda pharmacist. The supermarket chain said it was designed to provide a quick and accessible option for those 18 and […] The post Asda pharmacies launch earache service for adults appeared first on The Pharmacist.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we talk about the likely confirmation of FDA nominee Marty Makary, go in-depth on NIH nominee Jay Bhattacharya, and see how much 23andMe CEO Anne Wojcicki is willing to pay for her own company.
On National Safety Day 2025, the Indian Drug Manufacturers Association (IDMA) launches IDMA CARES, a dedicated initiative to strengthen workplace safety, Prevention of Sexual Harassment (POSH), and Environmental, Social, and Governance (ESG) principles. Under the campaign CARE Creating an Accountable, Respectful, and Empowered Workplace, IDMA aims to address: Workplace safety Ensuring the well-being of employees and communities POSH compliance Creating safe, inclusive, and harassment-free wor
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. I’m Liz Cooney, sitting in on Morning Rounds for Theresa today.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Biocon Academy, a Centre of Excellence for Advanced Learning in Applied Biosciences and a CSR initiative of Biocon Group, recently celebrated its 9th Graduation Day at its Bengaluru Campus. This years graduating class secured placements in top companies such as Biocon, Biocon Biologics, Syngene, Thermo Fisher Scientific Inc, Anthem Biosciences, Lupin, Merck, Baxter, Dr Reddy’s Laboratories, and Emcure among others.
The Unseen Heroes of Generic Drug Development: Pharmacovigilance As a generic drug developer, you're no stranger to the challenges of bringing affordable medications to market. From navigating complex regulatory landscapes to ensuring the quality and safety of your products, every step of the process requires meticulous attention to detail. But have you ever stopped to think about the unsung heroes of generic drug development?
Venus Remedies has received global marketing authorisation for Sugammadex from the Philippines. Sugammadex is a selective relaxant-binding agent (SRBA) used for the rapid reversal of neuromuscular blockade induced by rocuronium and vecuroniumtwo commonly used muscle relaxants in anaesthesia. Sugammadex directly encapsulates and inactivates these drugs, offering a faster, safer, and more predictable recovery from anaesthesia, and reducing the risk of post-operative respiratory complications.
This approval covers all indications of the reference products and the biosimilars are anticipated to be available by June 2025 in the country as per the settlement agreement with Amgen. The agencys decision is supported by clinical evidence, along with outcomes from Phase III trials in postmenopausal women with osteoporosis. The studies aimed to assess the pharmacodynamics, immunogenicity, pharmacokinetics, efficacy, and safety of CT-P41 compared to reference denosumab.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Senores Pharmaceuticals, through its wholly-owned subsidiary Senores Pharmaceuticals, has signed agreements to acquire a basket of 14 Abbreviated New Drug Applications (ANDAs) from Dr. Reddys Laboratories and its applicable affiliates. The basket acquired comprises 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA.
GPs have paused collective action after accepting a contract deal for 2025/26, the British Medical Association (BMA) has announced. Pharmacy leaders have welcomed this move and the potential for increased working between the sectors, but have said attention must now turn to community pharmacy negotiations. With community pharmacy contractual framework negotiations still ongoing, the chair […] The post Pharmacy action still on the table as GPs pause 'working to rule' appeared firs
Gene therapy has shown remarkable promise for treating rare diseases, but progress in addressing inborn errors of metabolism (IEM) has been hampered by unique challenges. IEMs are a group of rare genetic disorders that disrupt the body’s ability to metabolize food, often due to enzyme deficiencies. While gene therapy holds the potential to correct these underlying genetic defects, several obstacles hinder its development and implementation.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Striking study results last year indicated a new type of medicine may improve on Merck’s dominant immunotherapy, spurring a wave of research practically overnight.
The Central Drug Standard Control Organisation ( CDSCO) has launched an online process under the SUGAM portal for filing applications for the registration of clinical research organisations. The online registration of CROs is now functional on the SUGAM portal – www.cdscoonline.gov.in Applications for registrations can be submitted through the SUGAM portal only along with the prescribed list of documents.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content